Discovery screen platform for co-modulators of T cell effector function against tumors

被引:0
|
作者
Kim, Edward [1 ]
Sekar, Keerthana [1 ]
Sakamoto, Doreen [1 ]
Yen, David [1 ]
Lee, Fei [1 ]
Bailis, Julie [1 ]
Ouyang, Wenjun [1 ]
Zheng, Yan [1 ]
机构
[1] Amgen Inc, San Francisco, CA USA
来源
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
57.46
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins
    Quinn, ZA
    Yang, CC
    Wrana, JL
    McDermott, JC
    NUCLEIC ACIDS RESEARCH, 2001, 29 (03) : 732 - 742
  • [2] DISCOVERY AND DEVELOPMENT OF T CELL RECEPTORS FOR ADOPTIVE T CELL THERAPY AGAINST SOLID TUMORS
    Lujan, Juliana Velez
    Fields, Hannah
    Wu, Kan Xing
    Epstein, Natalie
    Chioh, Florence
    Tan, Nicholas
    Carbajo, Daniel
    Kulkarni, Neeraja
    Gerber, Lorenz
    Purwanti, Yovita
    Nardin, Alessandra
    Fehlings, Michael
    Fink, Katja
    Macleod, Dan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A307 - A307
  • [3] A discovery platform for allosteric modulators of c-Abl kinase function
    Grover, Prerna
    Smithgall, Thomas E.
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Outlast™ CAR-T Cells Exhibit Superior Effector Function Against Solid Tumors
    Carbajal, Kevin
    Anderson, Warren
    Ekambaram, Prasanna
    Gorczynski, Jessica
    Esquivel, Matthew
    Pecoraro, Adam
    Richter, Max
    Schroff, Matthias
    Jain, Sumiti
    MOLECULAR THERAPY, 2024, 32 (04) : 408 - 408
  • [5] CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus
    Textor, Ana
    Grunewald, Laura
    Anders, Kathleen
    Klaus, Anika
    Schwiebert, Silke
    Winkler, Annika
    Stecklum, Maria
    Rolff, Jana
    Henssen, Anton G.
    Hoepken, Uta E.
    Eggert, Angelika
    Schulte, Johannes H.
    Jensen, Michael C.
    Blankenstein, Thomas
    Kuenkele, Annette
    CANCERS, 2021, 13 (05) : 1 - 17
  • [6] GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cells
    Ibanez, Jorge
    Hebbar, Nikhil
    Thanekar, Unmesha
    Yi, Zhongzhen
    Houke, Haley
    Ward, Meghan
    Nevitt, Chris
    Tian, Liqing
    Mack, Stephen C.
    Sheppard, Heather
    Chiang, Jason
    Velasquez, M. Paulina
    Krenciute, Giedre
    CELL REPORTS MEDICINE, 2023, 4 (11)
  • [7] Targeting inducible T cell co-stimulator (ICOS) promotes effector T cell function and antitumor response
    Mayes, Patrick A.
    Yadavilli, Sapna
    Liu, Yao-Bin
    Bi, Meixia
    Zhang, Tianqian
    Sendeyo, Kelhia
    Willoughby, Jane
    Seestaller-Wehr, Laura
    Hahn, Ashleigh
    Bhattacharya, Sabyasachi
    DeYoung, M. Phillip
    Blackwell, Christina
    Shi, Hong
    Killian, David
    Adam, Michael
    Zhang, Shu-Yun
    Jing, Junping
    Hopson, Chris
    Marodon, Gilles
    Cragg, Mark S.
    Hoos, Axel
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [8] T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors
    Hu, Jiemiao
    Sun, Chuang
    Bernatchez, Chantale
    Xia, Xueqing
    Hwu, Patrick
    Dotti, Gianpietro
    Li, Shulin
    CLINICAL CANCER RESEARCH, 2018, 24 (12) : 2920 - 2934
  • [9] A T cell redirection platform for co-targeting dual antigens on solid tumors
    Enderle, Leonie
    Shalaby, Karim H.
    Gorelik, Maryna
    Weiss, Alexander
    Blazer, Levi L.
    Paduch, Marcin
    Cardarelli, Lia
    Kossiakoff, Anthony
    Adams, Jarrett J.
    Sidhu, Sachdev S.
    MABS, 2021, 13 (01)
  • [10] In vivo CRISPR screen reveals how to drive therapeutic T cell function to solid tumors
    Hong, Yeonsun
    Kim, Minsoo
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)